BNP PARIBAS ASSET MANAGEMENT Holding S.A.
Position in ONC — BeOne Medicines Ltd.
CIK 1520354
Paris, I0
Position in ONC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,563,837
+$547,633 QoQ
Shares Held
37,070
+9.9% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#51
of 282 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $2,249,207,592 across 136 Biotechnology names. ONC ranks #31 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
897,893 | $446,010,389 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
331,560 | $206,740,921 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
799,297 | $192,606,596 | |
| 4 | ARGX |
Argenx SE
|
121,786 | $112,989,396 | |
| 5 | INCY |
Incyte Corp
|
937,763 | $106,304,813 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
1,290,731 | $77,908,522 | |
| 7 | VCEL |
Vericel Corp
|
1,639,988 | $72,963,065 | |
| 8 | CYTK |
Cytokinetics Inc
|
827,810 | $70,521,132 |
All Filings in ONC
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,563,837 | 37,070 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $10,016,204 | 33,728 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $10,349,287 | 34,065 | Shares | Defined | 2026-02-13 | |
| 2025-03-31 | $21,334,861 | 78,388 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $14,784,927 | 80,044 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $21,978,406 | 97,895 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $13,928,729 | 97,629 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $15,337,636 | 98,073 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $18,571,669 | 102,970 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $17,238,740 | 95,840 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $16,761,626 | 94,008 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $20,081,145 | 93,171 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $20,862,848 | 94,857 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $10,332,604 | 76,640 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $12,666,703 | 78,262 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $31,474,322 | 166,884 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $44,952,163 | 165,918 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $56,963,775 | 156,925 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $22,443,939 | 65,398 | Shares | Defined | 2021-08-05 | |
| 2020-09-30 | $3,406,630 | 11,893 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $2,048,850 | 10,875 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $1,313,214 | 10,667 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||